Table 1.
HC (n = 35) | AD (n = 28) | SAD (n = 18) | GAD (n = 20) | |||||
---|---|---|---|---|---|---|---|---|
| ||||||||
M(SD) | % | M(SD) | % | M(SD) | % | M(SD) | % | |
Age | 17.40 (3.26) | 17.39(5.08) | 18.78 (3.75) | 17.00 (5.53) | ||||
Sex (% Female) | 60.0% | 67.9% | 72.2% | 80.0% | ||||
Site (% University of Michigan) | 17.1% | 25.0% | 22.2% | 25.0% | ||||
Treatment (% SSRI) | - | 57.1% | 66.7% | 45.0% | ||||
Comorbid GAD/SAD | 0.0% | 35.7% | 55.6% | 50.0% | ||||
Other comorbid anxiety | 0.0% | 25.0% | 33.3% | 30.0% | ||||
Comorbid depression | 0.0% | 14.3% | 22.2% | 10.0% | ||||
Number of sessions | - | 12.82(2.09) | 12.06(0.87) | 60.58(12.16) | ||||
Percent change in anxiety severity | - | 64.97(20.70) | 60.58(12.16) | 64.16(22.60) | ||||
ΔERN at Time 1 | −5.73(4.66) | −6.87(4.93) | −9.09(4.29) | −5.90(5.18) | ||||
ΔERN at Time 2 | −7.53(4.11) | −8.52(6.32) | −10.79(6.33) | −6.91(5.04) |